Similares a METRE-PL Data Shows Severe Metabolic Disease Burden in FPLD Despite Standard Therapy

20 vecinos (text_768) · 57 views · HCPLive · Estados Unidos


★	METRE-PL Data Shows Severe Metabolic Disease Burden in FPLD Despite Standard Therapy	HCPLive @hcplivenews	57	Estados Unidos
18	Diabetes Dialogue: Omnipod and AID Advancements at Insulet, With Trang Ly, PhD, MBBS	HCPLive @hcplivenews	4.3K	Estados Unidos	87
10	Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight	HCPLive @hcplivenews	1.1K	Estados Unidos	87
13	GLP-1 Therapies: Where We’ve Been & Where We’re Going	Conversations on Health Care @cohcpodcast	541	Estados Unidos	87
6	Diabetes Dialogue: Retatrutide Phase 3 Data Show Major Weight Loss	HCPLive @hcplivenews	533	Estados Unidos	88
14	TRIUMPH-2: Retatrutide Reduces Weight, A1C in Patients With Obesity	HCPLive @hcplivenews	350	Estados Unidos	87
8	Diabetes Dialogue: Weekly Insulin Icodec Now Available for Type 2 Diabetes	HCPLive @hcplivenews	206	Estados Unidos	88
9	Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA	HCPLive @hcplivenews	179	Estados Unidos	87
12	Rapid Evolution in GLP-1s and Therapeutics at ADA 2026	HCPLive @hcplivenews	171	Estados Unidos	87
11	Retatrutide Cuts Weight, Cardiovascular Disease Risk in TRIUMPH-3	HCPLive @hcplivenews	158	Estados Unidos	87
19	Insulin Icodec Dosing Strategies for Type 2 Diabetes	HCPLive @hcplivenews	105	Estados Unidos	87
16	Diabetes Dialogue: Diabetes Technology and Treatment in the UK, With Ketan Dhatariya, MD, PhD, MS	HCPLive @hcplivenews	94	Estados Unidos	87
20	Diabetes Dialogue: The International Diabetes Federation and Care in India, With Amit Gupta, MBBS	HCPLive @hcplivenews	79	Estados Unidos	87
7	Incretins, Monitors, and Insulin Titration at ADA 2026	HCPLive @hcplivenews	76	Estados Unidos	88
17	Secret Shopper Study Reveals GLP-1 Telehealth Gaps	HCPLive @hcplivenews	70	Estados Unidos	87
2	Synergy Between Metreleptin and GLP-1 Receptor Agonists in Lipodystrophy Real-World Data Suggest	HCPLive @hcplivenews	68	Estados Unidos	91
3	Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy	HCPLive @hcplivenews	55	Estados Unidos	90
4	When to Add GLP-1 Receptor Agonists to Metreleptin in Lipodystrophy, With Lindsay Fourman, MD	HCPLive @hcplivenews	44	Estados Unidos	89
1	Metreleptin-Neutralizing Antibodies Do Not Impact Treatment Outcomes in Generalized Lipodystrophy	HCPLive @hcplivenews	40	Estados Unidos	91
5	Continuous Ketone Monitoring May Guide SGLT2i Use in T1D	HCPLive @hcplivenews	33	Estados Unidos	88
15	Ersodetug Shows Target Engagement but Misses Primary Endpoints in Phase 3 cHI Study	HCPLive @hcplivenews	20	Estados Unidos	87